Pulmonary Arterial Hypertension-Market Insight Epidemiology 2027
Pulmonary Arterial Hypertension added by Reportsweb to its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
(EMAILWIRE.COM, September 05, 2018 ) 'Pulmonary Arterial Hypertension (PAH)-Market Insights, Epidemiology and Market Forecast-2027’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of PAH in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.
The Report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of Pulmonary Arterial Hypertension (PAH) from 2016 to 2027 segmented by seven major markets. The Report also covers current treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assess underlying potential of the market.
Get Sample Copy of the Report: http://www.reportsweb.com/inquiry&RW00011660533/sample
The Pulmonary Arterial Hypertension (PAH) epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Publisher report also provides the diagnosed and treatable patient pool and their trends along with assumptions undertaken.
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology (total prevalent cases, sex-specific prevalent cases, and sub-type specific prevalent cases) scenario of Pulmonary Arterial Hypertension (PAH)in the 7MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2016-2027.
According to Publisher, the total number of prevalent population of Pulmonary Arterial Hypertension (PAH) was found to be more than 70,000 in 7MM, in the year 2016. Women account for 70% of the total prevalent cases.
Table of Contents
1. Report Introduction
2. Pulmonary Arterial Hypertension Market Overview at a Glance
2.1. Global Market Share Distribution of Pulmonary Arterial Hypertension in 2016
2.2. Global Market Share Distribution of Pulmonary Arterial Hypertension in 2027
3. Pulmonary Arterial Hypertension (PAH): Overview
3.1. Signs and Symptoms
3.2. Classification of Pulmonary Arterial Hypertension (PAH)
3.3. Functional Classification of PAH
3.4. Etiology
3.5. Risk factors
3.6. Pathophysiology
3.7. Diagnosis
3.8. Treatment
5. Treatment Algorithm
5.1. United States
5.1.1. CHEST Guidelines
5.2. Europe
5.2.1. European Society of Cardiology (ESC) and of the European Respiratory Society (ERS) Guidelines
6. Unmet Needs
7. Marketed Products
7.1. Approval and Market Presence
7.2. Company-Wise Marketed Products
7.2.1. United Therapeutics Corporation
7.2.1.1. Comparative Analysis of Marketed Therapies
7.2.1.1.1.1. Mechanism of action
7.2.1.1.1.2. Regulatory Milestones
7.2.1.1.1.3. Safety and efficacy profiles
7.2.1.1.1.4. Side effects
Place Direct Purchase order For Complete report @ http://www.reportsweb.com/inquiry&RW00011660533/discount
The Report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of Pulmonary Arterial Hypertension (PAH) from 2016 to 2027 segmented by seven major markets. The Report also covers current treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assess underlying potential of the market.
Get Sample Copy of the Report: http://www.reportsweb.com/inquiry&RW00011660533/sample
The Pulmonary Arterial Hypertension (PAH) epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Publisher report also provides the diagnosed and treatable patient pool and their trends along with assumptions undertaken.
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology (total prevalent cases, sex-specific prevalent cases, and sub-type specific prevalent cases) scenario of Pulmonary Arterial Hypertension (PAH)in the 7MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2016-2027.
According to Publisher, the total number of prevalent population of Pulmonary Arterial Hypertension (PAH) was found to be more than 70,000 in 7MM, in the year 2016. Women account for 70% of the total prevalent cases.
Table of Contents
1. Report Introduction
2. Pulmonary Arterial Hypertension Market Overview at a Glance
2.1. Global Market Share Distribution of Pulmonary Arterial Hypertension in 2016
2.2. Global Market Share Distribution of Pulmonary Arterial Hypertension in 2027
3. Pulmonary Arterial Hypertension (PAH): Overview
3.1. Signs and Symptoms
3.2. Classification of Pulmonary Arterial Hypertension (PAH)
3.3. Functional Classification of PAH
3.4. Etiology
3.5. Risk factors
3.6. Pathophysiology
3.7. Diagnosis
3.8. Treatment
5. Treatment Algorithm
5.1. United States
5.1.1. CHEST Guidelines
5.2. Europe
5.2.1. European Society of Cardiology (ESC) and of the European Respiratory Society (ERS) Guidelines
6. Unmet Needs
7. Marketed Products
7.1. Approval and Market Presence
7.2. Company-Wise Marketed Products
7.2.1. United Therapeutics Corporation
7.2.1.1. Comparative Analysis of Marketed Therapies
7.2.1.1.1.1. Mechanism of action
7.2.1.1.1.2. Regulatory Milestones
7.2.1.1.1.3. Safety and efficacy profiles
7.2.1.1.1.4. Side effects
Place Direct Purchase order For Complete report @ http://www.reportsweb.com/inquiry&RW00011660533/discount
Contact Information:
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results